Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Contribution of Serine Residues to Constitutive and Agonist-Induced Signaling via the D2SDopamine Receptor: Evidence for Multiple, Agonist-Specific Active Conformations

Brenda L. Wiens, Cole S. Nelson and Kim A. Neve
Molecular Pharmacology August 1998, 54 (2) 435-444; DOI: https://doi.org/10.1124/mol.54.2.435
Brenda L. Wiens
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cole S. Nelson
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim A. Neve
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 54 no. 2 435-444
DOI 
https://doi.org/10.1124/mol.54.2.435
PubMed 
9687586

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received January 14, 1998
  • Accepted May 8, 1998
  • Published online August 1, 1998.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Brenda L. Wiens1,2,
  2. Cole S. Nelson3,4, and
  3. Kim A. Neve1,2,3
  1. 1Medical Research Service, Veterans Affairs Medical Center (B.L.W., K.A.N.), Departments of 2Behavioral Neuroscience (B.L.W., K.A.N.) and 3Physiology and Pharmacology (C.S.N., K.A.N.), 4 and Center for Research on Occupational and Environmental Toxicology (C.S.N.), Oregon Health Sciences University, Portland, Oregon 97201
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 1999 to January 2023

AbstractFullPdf
Jan 19992205
Feb 1999374
Mar 19992118
Apr 1999463
May 1999396
Jun 1999295
Jul 199911411
Aug 1999186
Sep 1999031
Oct 1999265
Nov 1999175
Dec 1999242
Jan 2000053
Feb 2000154
Mar 2000075
Apr 20000812
May 2000164
Jun 2000052
Jul 2000131
Aug 20000510
Sep 2000048
Oct 2000133
Nov 2000164
Dec 2000032
Jan 2001202
Feb 2001336
Mar 2001076
Apr 2001178
May 2001223
Jun 2001059
Jul 2001145
Aug 20012126
Sep 2001246
Oct 2001079
Nov 2001059
Dec 20010113
Jan 20022610
Feb 2002154
Mar 2002065
Apr 20023413
May 200211110
Jun 2002459
Jul 20022814
Aug 2002043
Sep 2002047
Oct 2002133
Nov 2002142
Dec 2002014
Jan 2003101
Feb 2003077
Mar 2003175
Apr 2003155
May 2003025
Jun 2003348
Jul 200392311
Aug 200311154
Sep 2003112012
Oct 200382313
Nov 2003161813
Dec 2003132811
Jan 2004121610
Feb 20046162
Mar 200410257
Apr 20048214
May 20048206
Jun 200412251
Jul 2004143710
Aug 200414264
Sep 200413212
Oct 2004112411
Nov 200412258
Dec 2004694
Jan 200512254
Feb 20059195
Mar 200592811
Apr 20052186
May 2005193
Jun 20057161
Jul 20052148
Aug 200551410
Sep 20053175
Oct 20054104
Nov 20054101
Dec 20057144
Jan 200631410
Feb 20066172
Mar 20062123
Apr 20060119
May 200652012
Jun 2006076
Jul 2006171
Aug 2006087
Sep 2006064
Oct 2006194
Nov 20063141
Dec 2006362
Jan 2007143
Feb 2007032
Mar 2007262
Apr 2007355
May 2007184
Jun 20071115
Jul 2007173
Aug 2007342
Sep 2007083
Oct 2007364
Nov 20072131
Dec 20070124
Jan 2008231
Feb 2008338
Mar 2008263
Apr 2008466
May 2008121
Jun 200881210
Jul 20080143
Aug 20081173
Sep 20084133
Oct 2008632
Nov 2008201
Dec 2008112
Jan 2009331
Feb 2009022
Mar 2009233
Apr 2009262
May 2009212
Jun 2009035
Jul 2009383
Aug 2009255
Sep 2009692
Oct 2009720
Nov 2009312
Dec 2009620
Jan 2010120
Feb 2010434
Mar 2010755
Apr 2010141
May 2010120
Jun 2010032
Jul 2010121
Aug 2010145
Sep 2010302
Oct 2010454
Nov 2010131
Dec 2010533
Jan 2011241
Feb 2011567
Mar 20116109
Apr 2011062
May 20113211
Jun 20114720
Jul 2011456
Aug 2011223
Sep 2011226
Oct 2011453
Nov 2011580
Dec 2011344
Jan 2012041
Feb 2012211
Mar 2012210
Apr 2012032
May 2012131
Jun 2012935
Jul 20121025
Aug 2012520
Sep 2012721
Oct 20121066
Nov 2012468
Dec 201241011
Jan 2013343
Feb 20134910
Mar 2013295
Apr 2013663
May 2013495
Jun 2013136
Jul 2013324
Aug 2013101
Sep 2013211
Oct 2013224
Nov 2013101
Dec 2013002
Jan 2014744
Feb 2014307
Mar 2014256
Apr 2014019
May 20145512
Jun 20143412
Jul 2014303
Aug 2014034
Sep 2014018
Oct 2014330
Nov 2014240
Dec 2014251
Jan 2015233
Feb 2015362
Mar 2015122
Apr 2015300
May 2015030
Jun 2015262
Jul 2015383
Aug 2015061
Sep 2015261
Oct 2015421
Nov 2015410
Dec 2015612
Jan 20161428
Feb 20161457
Mar 2016609
Apr 2016217
May 2016006
Jun 2016405
Jul 2016430
Aug 2016377
Sep 2016133
Oct 2016132
Nov 2016154
Dec 2016021
Jan 2017020
Feb 2017031
Mar 2017030
Apr 2017021
May 2017082
Jun 2017756
Jul 2017055
Aug 2017141
Sep 20171151
Oct 2017082
Nov 20175172
Dec 2017682
Jan 20182267
Feb 2018184
Mar 20183132
Apr 20180134
May 20181235
Jun 20181162
Jul 2018285
Aug 2018261
Sep 2018061
Oct 20180213
Nov 20182112
Dec 2018965
Jan 20191001
Feb 20191411
Mar 2019500
Apr 20191210
May 2019802
Jun 2019923
Jul 2019611
Aug 2019921
Sep 20191151
Oct 2019712
Nov 20192431
Dec 20191242
Jan 20201052
Feb 20201251
Mar 2020522
Apr 2020400
May 2020011
Jun 20201000
Jul 2020610
Aug 2020301
Sep 2020220
Oct 20201131
Nov 2020300
Dec 2020840
Jan 20215152
Feb 2021880
Mar 20211143
Apr 2021921
May 20211353
Jun 2021250
Jul 20211771
Aug 2021140
Sep 2021230
Oct 2021330
Nov 2021810
Dec 20211620
Jan 20222733
Feb 2022741
Mar 2022110
Apr 2022431
May 20228152
Jun 20221310
Jul 2022810
Aug 20222010
Sep 2022420
Oct 20222450
Nov 2022310
Dec 2022731
Jan 2023620

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 54 (2)
Molecular Pharmacology
Vol. 54, Issue 2
1 Aug 1998
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Contribution of Serine Residues to Constitutive and Agonist-Induced Signaling via the D2SDopamine Receptor: Evidence for Multiple, Agonist-Specific Active Conformations
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Contribution of Serine Residues to Constitutive and Agonist-Induced Signaling via the D2SDopamine Receptor: Evidence for Multiple, Agonist-Specific Active Conformations

Brenda L. Wiens, Cole S. Nelson and Kim A. Neve
Molecular Pharmacology August 1, 1998, 54 (2) 435-444; DOI: https://doi.org/10.1124/mol.54.2.435

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Contribution of Serine Residues to Constitutive and Agonist-Induced Signaling via the D2SDopamine Receptor: Evidence for Multiple, Agonist-Specific Active Conformations

Brenda L. Wiens, Cole S. Nelson and Kim A. Neve
Molecular Pharmacology August 1, 1998, 54 (2) 435-444; DOI: https://doi.org/10.1124/mol.54.2.435
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics